Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids

Duchenne muscular dystrophy (DMD) is an X-linked inherited disorder. Patients present with decreased bone mineral density (BMD) due to glucocorticoid therapy and progressive muscle weakness. Bone remodeling allows bone volume and structure to be maintained and controlled by local and systemic factor...

Full description

Bibliographic Details
Main Authors: Salvador Atilano-Miguel, Lourdes Barbosa-Cortés, Rocío Ortiz-Muñiz
Format: Article
Language:English
Published: Permanyer 2022-01-01
Series:Boletín Médico del Hospital Infantil de México
Subjects:
Duchenne muscular dystrophy. RANK ligand. Osteoprotegerin (OPG). Receptor activator of nuclear factor-kappa B (RANKL). Glucocorticoids.
Online Access:https://www.bmhim.com/frame_esp.php?id=324

Internet

https://www.bmhim.com/frame_esp.php?id=324

Similar Items